BTG PLC (LSE:BTG) - Share price - Overview


Stock Report

BTG PLC BTG

Last Price
GBX834.00

Day Change
0.50|0.06%

As of 18/04/2019
18:47:21 BST | GBX
Minimum 15 Minutes Delay.

Last Close833.50p
Day Range833.00 - 834.50
Mkt Cap-
52-Wk Range467.40 - 853.00
Yield %0.00
ISINGB0001001592
Volume535,194
P/E2,342.70
P/S3.73
P/CF19.17

Share Price

Total Returns 22/04/2019

 Chg (%)  
More ...
BTG PLC0.36 
FTSE 100 TR GBP2.67
 
Financials
201620172018
More ...
Income Statement
Turnover643.10711.81869.63
Operating Profit81.2068.2571.34
Net Profit86.9441.9217.80
Reported EPS0.220.110.06
Balance Sheet
Current Assets427.54427.09571.81
Non Current Assets1,223.401,208.761,057.71
Total Assets1,650.931,635.851,629.53
Current Liabilities179.64206.49266.43
Total Liabilities---
Total Equity1,218.221,222.611,279.29
Cash Flow
Operating Cash Flow146.30105.56190.18
Net Change in Cash94.4211.4888.72

Regulatory News

DateAuthor Headline
14/11/2017David Brenchley Invesco's Mark Barnett: Why I'm Investing in Oil
BP and Shell are now more profitable than when oil was trading above $100 a barrel, argues the Invesco Perpertual fund manager
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
23/11/2018Exercise of OptionDame Pamela Louise Makin DBE504.407133,596.00
23/07/2018PurchaseMs Anne Thorburn499.8115,00074,972.00
17/07/2018Transfer inDame Pamela Louise Makin DBE0.00155,8000.00
17/07/2018SaleDame Pamela Louise Makin DBE487.8873,410358,155.00

Company Profile

BTG PLC is engaged in business of healthcare focusing on Interventional Medicine therapies for cancer, severe emphysema, severe bloodclots and varicose veins, and Specialty Pharmaceuticals for acute care uses, and a licensing business.

Sector

Biotechnology

Index

FTSE 250 ,FTSE 350 ,FTSE All Share ,FTSE techMARK Focus ,FTSE techMARK All Share

Next Event 15/05/2019

Final Results
Ratios
Comp
More ...
PER (E)142.09
Div Yld (E)0.00
PEG (E)0.00
ROCE5.23
Op Mrgn0.08
EPS Grwth1.02
Dividends
PreviousLatest
More ...
Record Date25/07/9717/07/98
Ex-Div21/07/9713/07/98
Paid08/08/9707/08/98
Amnt0.720.75
Directors
More ...
Non-Executive DirectorMs Anne Thorburn
Executive Director, Chief Executive OfficerDame Pamela Louise Makin DBE
Non-Executive DirectorMr. Richard Leslie Martin Wohanka
Executive Director, Chief Financial OfficerDuncan Kennedy
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.